Alzheimer Drugs Market
Alzheimer's Drugs Market Report 2024, with Profiles of 10+ Companies Including AbbVie, Biogen, Daiichi Sankyo, Eisai, Eli Lilly, H. Lundbeck, Lupin, Merck, Novartis, Pfizer, Teva Pharmaceutical & More
29 oct. 2024 11h30 HE | Research and Markets
Dublin, Oct. 29, 2024 (GLOBE NEWSWIRE) -- The "Alzheimer's Drugs - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering.The global market for Alzheimer's Drugs is...
Transparency Market Research
Alzheimer’s Drugs Market on Track for USD 11.6 Billion Expansion with 10.0% Annual Growth by 2034- Transparency Market Research, Inc.
21 août 2024 12h29 HE | Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research, Inc., Aug. 21, 2024 (GLOBE NEWSWIRE) -- As per the report published by Transparency Market Research, the global Alzheimer's drugs...
Alzheimer Drugs Market
Global and China Alzheimer's Drugs Research Report 2024-2032 Featuring Industry Leaders - Abbvie, AstraZeneca, Biogen, Eisai, Eli Lilly, Lundbeck, Roche, Merck, Novartis, Ono, Pfizer, and Teva
25 juin 2024 07h20 HE | Research and Markets
Dublin, June 25, 2024 (GLOBE NEWSWIRE) -- The "Alzheimer's Drugs Market Report by Drug Class, Drug Type, Distribution Channel, Region and Company Analysis 2024-2032" report has been added to ...
22157.jpg
Japan Alzheimer's Disease Market Forecast to 2032 Demonstrates Increasing Diagnosed Prevalence and Growth Following Novel Treatment Approaches
25 janv. 2024 09h02 HE | Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Japan Alzheimer's Disease - Market Insight, Epidemiology and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The...
22157.jpg
Global Alzheimer's Disease Industry Forecast, 2032: Breakthrough Therapies and Market Trends
23 août 2023 05h53 HE | Research and Markets
Dublin, Aug. 23, 2023 (GLOBE NEWSWIRE) -- The "Global Alzheimer's Disease Market 2023-2032" report has been added to ResearchAndMarkets.com's offering. Alzheimer's disease, a progressive...
Alzheimer Disease Therapeutics Market
Global Alzheimer's Disease Therapeutics Market Research Report 2023: Forecasts, Epidemiology & Pipeline Analysis 2022-2028
08 févr. 2023 10h23 HE | Research and Markets
Dublin, Feb. 08, 2023 (GLOBE NEWSWIRE) -- The "Alzheimer's Disease Therapeutics Market Forecast - Epidemiology & Pipeline Analysis 2023-2028" report has been added to ResearchAndMarkets.com's...
Alzheimer Drugs Market
Global Alzheimer's Drugs Market Report 2023 - 2027: Key Players Include Sanofi, F. Hoffmann-La Roche, Pfizer and Abbott Laboratories
24 janv. 2023 09h13 HE | Research and Markets
Dublin, Jan. 24, 2023 (GLOBE NEWSWIRE) -- The "Alzheimer's Drugs Market, Global Forecast 2023-2027, Industry Trends, Growth, Insight, Impact of Inflation, Company Analysis" report has been added to ...
Alzheimer’s Therapeutics Market
Alzheimer's Therapeutics Market Research Report 2022 Featuring Cipla, Torrent Pharma, Unichem, Lannett, Janssen Pharma, Novartis, Zydus Lifesciences, Sun Pharmaceutical, Dr. Reddy's, and Aurobindo
13 déc. 2022 05h13 HE | Research and Markets
Dublin, Dec. 13, 2022 (GLOBE NEWSWIRE) -- The "Alzheimer's Therapeutics Market Share, Size, Trends By Drug Class, By Distribution Channel, By Region, Segment Forecast, 2022 - 2030" report has been...
22157.jpg
Alzheimers Therapeutic Global Market Report 2022: High Estimates of Future Cases Driving Development & Innovation
11 oct. 2022 05h18 HE | Research and Markets
Dublin, Oct. 11, 2022 (GLOBE NEWSWIRE) -- The "Alzheimers Therapeutic Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...
Global Alzheimer’S Disease Treatment Market
Global Alzheimer's Disease Treatment Market Report 2022: Market is Expected to Reach $6.94 Billion in 2026 at a CAGR of 8.1% - Long-term Forecast to 2031
01 juin 2022 05h23 HE | Research and Markets
Dublin, June 01, 2022 (GLOBE NEWSWIRE) -- The "Alzheimer's Disease Treatment Global Market Report 2022: By Drug, By Drug, By Therapeutics" report has been added to ResearchAndMarkets.com's offering....